8-K filed May 6, 2026, 7:59 PM ET ticker BNGO CIK 0001411690

leadership confidence high sentiment negative materiality 0.65

Bionano Genomics CEO Erik Holmlin terminated; Chairman Al Luderer named interim CEO

Bionano Genomics, Inc.

CEO Erik Holmlin terminated effective May 5, 2026; will serve as advisor under consulting agreement.
Board appoints Chairman Albert Luderer as interim CEO and interim principal financial officer.
Luderer receives $600k base salary, up to $400k bonus, and $4k/month housing/travel stipend.
Chris Twomey appointed Lead Independent Director to support governance during transition.
Company will immediately commence search for a permanent CEO.

item 5.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001411690-26-000019
form_type: 8-K
ticker: BNGO
cik: 0001411690
company_name: Bionano Genomics, Inc.
filed_at: 2026-05-06T23:59:59+00:00
discovered_at: 2026-05-14T18:02:32.252239+00:00
generated_at: 2026-05-14T22:35:12.802586+00:00
sec_items: ["5.02", "8.01", "9.01"]
event_type: leadership
sentiment: negative
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001411690-26-000019
json_url: https://secwatch.observer/filing/0001411690-26-000019.json
markdown_url: https://secwatch.observer/filing/0001411690-26-000019.md
text_url: https://secwatch.observer/filing/0001411690-26-000019.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1411690/000141169026000019/0001411690-26-000019-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1411690/000141169026000019/bngo-20260505.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Albert A. Luderer

Interim Chief Executive Officer

BNGO · Bionano Genomics, Inc.

Effective: 2026-05-05
Filed: May 6, 2026, 7:59 PM ET

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

Departed

Erik Holmlin

President and Chief Executive Officer

BNGO · Bionano Genomics, Inc.

Effective: 2026-05-05
Successor: Albert A. Luderer
Filed: May 6, 2026, 7:59 PM ET

On May 5, 2026 (the “Effective Date”), Bionano Genomics, Inc. (the “Company”) R. Erik Holmlin, Ph.D. was terminated as the Company’s President and Chief Executive Officer, effective immediately.

Source-grounded claims

d3360a8193

Albert A. Luderer was appointed as Interim Chief Executive Officer at Bionano Genomics, Inc..

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

edf2ccb15b

Erik Holmlin was terminated as President and Chief Executive Officer at Bionano Genomics, Inc..

On May 5, 2026 (the “Effective Date”), Bionano Genomics, Inc. (the “Company”) R. Erik Holmlin, Ph.D. was terminated as the Company’s President and Chief Executive Officer, effective immediately.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

GRAL

GRAIL appoints Joshua Ofman as CEO with amended compensation and severance

GRAIL, Inc. June 1, 2026, 4:07 PM ET leadership Items 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 8.01, 9.01 same event type: leadership similar materiality

This filing

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

Comparable filing

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers In connection with Dr. Joshua Ofman’s appointment as the Chief Executive Officer of GRAIL, Inc. (the “Company”), on June 1, 2026, the Company’s board of directors (the “Board”) approved an amended and restated offer letter (the “Amended Offer Letter”) and authorized and directed the Company to enter into such Amended Offer Letter with Dr. Ofman, with the Amended Offer Letter effective as of June 1, 2026 (the “Effective Date”).

Filing page SEC filing

ARQ

Arq appoints Shimon Steinmetz as CFO, CAO Stacia Hansen resigns

Arq, Inc. May 27, 2026, 4:32 PM ET leadership Items 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 8.01, 9.01 same event type: leadership similar materiality

This filing

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

Comparable filing

On May 20, 2026, Stacia Hansen, the Chief Accounting Officer and Treasurer of the Company, submitted her resignation and the Board accepted such resignation. The effective date of Ms. Hansen's resignation as Chief Accounting Officer is expected to be June 12, 2026.

Filing page SEC filing

CRVL

CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026

CORVEL CORP June 1, 2026, 5:05 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

Comparable filing

In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.

Filing page SEC filing

WTTR

Select Water Solutions COO Skarke moves to Chief Commercial Officer; no successor named

Select Water Solutions, Inc. June 1, 2026, 5:00 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

Comparable filing

Effective June 1, 2026, Michael C. Skarke transitioned from serving as the Executive Vice President and Chief Operating Officer of Select Water Solutions, Inc. (the “Company”) to serving as the Company’s Executive Vice President and Chief Commercial Officer,

Filing page SEC filing

TTD

The Trade Desk appoints Nate Olmstead as CFO effective July 9, 2026; interim CFO Davis resumes CAO role

Trade Desk, Inc. June 1, 2026, 4:35 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

Comparable filing

On June 1, 2026, The Trade Desk, Inc. (the “Company”) announced the appointment of Nate Olmstead, age 54, as the Company’s chief financial officer.

Filing page SEC filing

WST

West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair

WEST PHARMACEUTICAL SERVICES INC June 1, 2026, 4:32 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

Comparable filing

As of the Start Date, Mr. Green will resign as a member of the Board and Mr. Lagarde will be appointed as a member of the Board to fill that vacancy.

Filing page SEC filing

LPX

LP Building Solutions announces CFO succession: Alan Haughie to retire; Aaron Howald named CFO effective Sept 1, 2026

LOUISIANA-PACIFIC CORP June 1, 2026, 4:31 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

Comparable filing

On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.

Filing page SEC filing

VRRM

Verra Mobility CEO David Roberts steps down amid cost realignment; interim CEO Keyser appointed

VERRA MOBILITY Corp June 1, 2026, 4:29 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

As of the Effective Date, the Board appointed Albert A. Luderer, Ph.D., who currently serves as the Company’s Chairman of the Board, as the Company’s Interim Chief Executive Officer.

Comparable filing

On June 1, 2026, Verra Mobility Corporation (the “Company”) announced that the Board of Directors of the Company (the “Board”) approved the appointment of Jonathan Keyser as the Interim President and Chief Executive Officer of the Company, effective May 31, 2026.

Filing page SEC filing

Source: SEC EDGAR

accession 0001411690-26-000019

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.